Huifeng Bio-pharmaceutical Technology (fka HFGB)

[pappy]

I was looking for $0.06 to $0.08 in the 3rd & 4th qtr.

HFGB came in with $0.08 vs $0.05 last year when far fewer shares were outstanding.

For 9M eps of $0.18 vs $0.07 in 2009.

They guided for revenue of $20-$25M but are on pace to outdue the high end of revenue guidance.

Earning should also exceed the high end of guidance with latest 12 month eps now @ $).26 up from $0.15 for all of 2009 when far fewer shares were outstanding.

True with the 6.5M new shares added in eps won't be $0.26 for 2010,however with management able to deliver this kind of growth & further revenue gains of $20M expected from building the new plant its hard to 2nd guess why management found it necessary to raise cash below B.V. to get the additional plant done.